Patients with metabolic dysfunction-associated steatotic liver disease have preserved <i>in vitro</i> responses to antiplatelet drugs.

Patients with metabolic dysfunction-associated steatotic liver disease have preserved in vitro responses to antiplatelet drugs.

van den Boom, Bente P; van Beek, André P; Adelmeijer, Jelle; Blokzijl, Hans; Lisman, Ton.

Afiliação

van den Boom BP; Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Beek AP; Department of Internal Medicine, Division of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Adelmeijer J; Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Blokzijl H; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Lisman T; Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Res Pract Thromb Haemost ; 7(7): 102217, 2023 Oct.

Article em En | MEDLINE | ID: mdl-38077811